May 2022 Issue Table Of Contents
Source: Life Science Leader

From The Editor
Feature Articles
CEO Corner
Companies To Watch
Industry Research
Industry Leader
- 5 Life Science Trends To Watch
- A Nigerian Student’s Striking Pictures Illustrate Lessons We All Must Learn
Inside The Industry
- Key Considerations In Early-Stage Biopharma Financing
- The Future Of The Life Sciences Industry And What You Need To Know
- Embracing Challenges And Executing A Successful IPO
- Is Biopharma Poised For Bigger Deals In 2022?
- Is A Key Function To Product Launch Excellence Being Overlooked?
- Patents Or Trade Secrets? How To Choose The Best IP Safeguard For R&D Assets
- Platforms To Pipelines: Part 2
- Are Cannabinoids The Next Blockbuster Drugs? A Q&A With Jazz Pharma’s CEO Bruce Cozadd
Leadership Lessons
Ask The Board
- Following The Approval Of Biogen’s Aduhelm, There Has Been Talk About “Reining In” The FDA’s Accelerated Approval Pathway. How Important Is Accelerated Approval For Rare Disease Drugs?
- How Can Digital Technology Improve The Treatment Of Neurological Disorders?
- How Can I Prepare To Join And Serve On A Board Of Directors?
This website uses cookies to ensure you get the best experience on our website. Learn more